PKM and neoplasm: On the other hand, miR-4417 acted as an oncogene, where it decreased the expression of TRIM35, a protein previously identified as a tumor suppressor [307], promoted PKM2 Tyr-105 phosphorylation, increased proliferation, and reduced apoptosis in an HCC model [308].